Figure 2 | Scientific Reports

Figure 2

From: Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia

Figure 2

Clonal evolution in UPN8. (A) Comparison of VAFs of mutated genes detected by whole-exome sequence analysis between ET and transformed AML cells. ZNF143S286R, UBR4R450H, and SMARCC2D381E mutations were identified at the same VAF levels in ET and transformed AML cells. (B) Mutation analysis in HSC and HPCs. Mutation statuses of JAK2V617F, TP53R248W, ZNF143S286R, UBR4R450H, and SMARCC2D381E in HSC, CMP, GMP, and MEP fractions were analyzed. (C) Single-cell mutation analysis of BM samples at CR after chemotherapy for transformed AML. CD34+/CD38- cells were sorted as single cells, and we analyzed JAK2V617F, TP53R248W, TP53V173L, ZNF143S286R, UBR4R450H, and SMARCC2D381E mutations. The closed square and triangle indicate homozygous and heterozygous mutations, respectively.

Back to article page